SEC Form 4 · accession 0001179110-18-005403
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jingshyh S su
Director
Period of report
Apr 2, 2018
Accepted (ET)
Apr 4, 2018 · 4:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (Right to Buy)F1,F2 | $12.72 | Apr 2, 2018 | A | 63,290 | A | — | Apr 1, 2028 | Ordinary Shares | 63,290 | 63,290 | D |
Explanation of responses
- F1The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share ("ADS") represents 13 Ordinary Shares.
- F2The option shall become exercisable in equal installments on the first, second and third anniversary of the grant date and shall become exercisable in full on the date of the third annual meeting of shareholders following the grant date. All vesting shall cease if the reporting person resigns from the board or otherwise ceases to serve as a director, unless the board determines that the circumstances warrant the continuation of vesting.